NeoGenomics, Inc.

NEO

$9.26

Name : NeoGenomics, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $1,195,548,160.00

EPSttm : -0.82

NeoGenomics, Inc.

$9.26

2.49%

$0.225

Float Short %

4.73

Margin Of Safety %

Put/Call OI Ratio

0.22

EPS Next Q Diff

0.02

EPS Last/This Y

0.72

EPS This/Next Y

0.1

Price

9.02

Target Price

9.35

Analyst Recom

2.33

Performance Q

19.92

Relative Volume

2.09

Beta

1.64

Ticker: NEO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	NEO	7.93	0.23	0.10	26567
2025-09-09	NEO	7.86	0.23	0.32	26580
2025-09-10	NEO	7.48	0.23	0.57	26759
2025-09-11	NEO	8.34	0.24	0.03	26823
2025-09-12	NEO	7.97	0.23	0.03	27244
2025-09-15	NEO	8.08	0.23	0.04	27599
2025-09-16	NEO	7.99	0.22	0.35	28178
2025-09-17	NEO	8.11	0.22665505226481	0.0080563947633434	28164
2025-09-18	NEO	8.62	0.23	0.10	27966
2025-09-19	NEO	8.52	0.23	0.01	28051
2025-09-22	NEO	8.42	0.26	0.00	23379
2025-09-23	NEO	8.15	0.25	3.22	24174
2025-09-24	NEO	7.86	0.24	0.38	24274
2025-09-25	NEO	7.86	0.24	1.12	24280
2025-09-26	NEO	7.93	0.25	0.04	24402
2025-09-29	NEO	7.77	0.25	1.58	24530
2025-09-30	NEO	7.72	0.25	0.23	24604
2025-10-01	NEO	8.72	0.25	0.03	24673
2025-10-02	NEO	8.98	0.24	0.00	25984
2025-10-03	NEO	9.1	0.23	0.03	26455
2025-10-06	NEO	9.1	0.23	0.21	26676
2025-10-07	NEO	9.02	0.22	0.20	26789
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	NEO	7.93	-52.3	-	0.10
2025-09-09	NEO	7.86	-52.3	-	0.10
2025-09-10	NEO	7.48	-52.3	-	0.10
2025-09-11	NEO	8.34	-52.3	-	0.10
2025-09-12	NEO	7.97	-52.3	-	0.10
2025-09-15	NEO	8.09	-52.3	-	0.10
2025-09-16	NEO	7.99	-52.3	-	0.10
2025-09-17	NEO	8.11	-52.3	-	0.10
2025-09-18	NEO	8.63	-52.3	-	0.10
2025-09-19	NEO	8.52	-52.3	-	0.10
2025-09-22	NEO	8.40	-52.3	-	0.10
2025-09-23	NEO	8.15	-52.3	-	0.10
2025-09-24	NEO	7.86	-52.3	-	0.10
2025-09-25	NEO	7.86	-52.3	-	0.10
2025-09-26	NEO	7.93	-52.3	-	0.10
2025-09-29	NEO	7.77	-52.3	-	0.10
2025-09-30	NEO	7.72	-52.3	-	0.10
2025-10-01	NEO	8.72	-52.3	-	0.10
2025-10-02	NEO	8.94	-52.3	-	0.10
2025-10-03	NEO	9.10	-52.3	-	0.10
2025-10-06	NEO	9.11	-52.3	-	0.10
2025-10-07	NEO	9.02	-52.3	-	0.10
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	NEO	2.82	0.16	4.29
2025-09-09	NEO	2.82	0.16	4.29
2025-09-10	NEO	2.82	0.16	4.29
2025-09-11	NEO	2.82	0.16	4.18
2025-09-12	NEO	2.82	0.16	4.18
2025-09-15	NEO	2.82	0.16	4.18
2025-09-16	NEO	2.82	0.16	4.18
2025-09-17	NEO	2.82	0.16	4.18
2025-09-18	NEO	2.82	0.16	4.18
2025-09-19	NEO	2.82	0.16	4.18
2025-09-22	NEO	2.82	0.21	4.18
2025-09-23	NEO	2.82	0.21	4.18
2025-09-24	NEO	2.82	0.21	4.18
2025-09-25	NEO	2.82	0.21	4.73
2025-09-26	NEO	2.82	0.21	4.73
2025-09-29	NEO	2.82	0.21	4.73
2025-09-30	NEO	2.82	0.21	4.73
2025-10-01	NEO	2.82	0.21	4.73
2025-10-02	NEO	2.82	0.21	4.73
2025-10-03	NEO	2.82	0.21	4.73
2025-10-06	NEO	2.82	-1.90	4.73
2025-10-07	NEO	2.82	-1.90	4.73
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.03

Avg. EPS Est. Current Quarter

0.02

Avg. EPS Est. Next Quarter

0.05

Insider Transactions

2.82

Institutional Transactions

-1.9

Beta

1.64

Average Sales Estimate Current Quarter

183

Average Sales Estimate Next Quarter

189

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

85.4

Max Drawdown 5-Year %

-91.9

Target Price

9.35

P/E

Forward P/E

50.09

PEG

P/S

1.69

P/B

1.36

P/Free Cash Flow

EPS

-0.82

Average EPS Est. Cur. Y

0.1

EPS Next Y. (Est.)

0.2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-15.1

Relative Volume

2.09

Return on Equity vs Sector %

-37.4

Return on Equity vs Industry %

-23.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

NeoGenomics, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 2200

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through two segments: Clinical Services and Advanced Diagnostics. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

stock quote shares NEO – Neogenomics Inc. Stock Price stock today

news today NEO – Neogenomics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch NEO – Neogenomics Inc. yahoo finance google finance

stock history NEO – Neogenomics Inc. invest stock market

stock prices NEO premarket after hours

ticker NEO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NEO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y